» Articles » PMID: 39261381

Association of Race and Postoperative Outcomes in Patients with Inflammatory Bowel Disease

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2024 Sep 11
PMID 39261381
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous literature suggests that rates of postoperative complications following inflammatory bowel disease (IBD) surgery differ based on race.

Aims: The purpose of this study was to examine the association between race and adverse events and wound complications in patients with IBD.

Methods: This was a retrospective cohort study of the American College of Surgeons National Surgery Quality Improvement Program Inflammatory Bowel Disease Collaborative from 2017 to 2022. The data was collected from 15 high-volume IBD centers across the United States. The data was analyzed using crude and multivariable logistic regressions.

Results: 4284 patients were included in the study. Overall rates of adverse events and wound complications were 20.3% and 11.3%, respectively, and did not differ based on race on bivariate analysis. Rates of adverse events were 20.0% vs 24.6% vs 22.1%, p = 0.13 for white, black and other minority subjects, respectively. The adjusted odds of adverse events were higher for black subjects (1.46 [95%CI 1.0-2.1], p = 0.03) compared to white subjects. No difference in adverse events was found between other minority subjects and either black or white subjects (1.29 [0.7-2.3], p = 0.58). Race was not associated with likelihood of wound complications in the final analysis.

Conclusions: We found that a subset of black patients with IBD continue to experience more adverse events compared to white patients, primarily driven by a higher need for postoperative blood transfusion. Nonetheless, known risk factors, including comorbid conditions, decreased BMI, open surgery, and emergency surgery have a stronger association with postoperative complications than race alone.

References
1.
Dahlhamer J, Zammitti E, Ward B, Wheaton A, Croft J . Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years - United States, 2015. MMWR Morb Mortal Wkly Rep. 2016; 65(42):1166-1169. DOI: 10.15585/mmwr.mm6542a3. View

2.
Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U . Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. J Crohns Colitis. 2017; 11(7):769-784. DOI: 10.1093/ecco-jcc/jjx009. View

3.
Lamb C, Kennedy N, Raine T, Hendy P, Smith P, Limdi J . British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019; 68(Suppl 3):s1-s106. PMC: 6872448. DOI: 10.1136/gutjnl-2019-318484. View

4.
Fakhoury M, Negrulj R, Mooranian A, Al-Salami H . Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res. 2014; 7:113-20. PMC: 4106026. DOI: 10.2147/JIR.S65979. View

5.
Barnes E, Nowell W, Venkatachalam S, Dobes A, Kappelman M . Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States. Inflamm Bowel Dis. 2021; 28(7):983-987. DOI: 10.1093/ibd/izab219. View